Mercury Levels in Newborns and Infants After Receipt of Thimerosal-Containing Vaccines
This article, published in Pediatrics, reports on a study assessing blood levels and the elimination of ethyl mercury after vaccination of infants with thimerosal-containing vaccines. The authors concluded that the blood half-life of intramuscular ethyl mercury from thimerosal in vaccines in infants is substantially shorter than that of oral methyl mercury in adults. Because of the differing pharmacokinetics of ethyl and methyl mercury, exposure guidelines based on oral methyl mercury in adults may not be accurate for risk assessments in children who receive thimerosal-containing vaccines. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: Pichichero ME, Gentile A, Giglio N, et al.
» Visit web page (English)
(Located at pediatrics.aappublications.org)
Citation: Pichichero ME, Gentile A, Giglio N, et al. Mercury Levels in Newborns and Infants After Receipt of Thimerosal-containing Vaccines. Pediatrics. 2008;121(2):e208-e214.
Resource types: Peer-reviewed journal
Diseases/vaccines: Not disease/vaccine specific
Topics: Vaccine safety and performance